Success stories Archive - Page 27 sur 45 - Prestwick Chemical Libraries

success-story

Success Stories


Publications
An in vivo zebrafish screen identifies organophosphate antidotes with diverse mechanisms of action.

Journal of biomolecular screening

Jin S, Sarkar KS, Jin YN, Liu Y, Kokel D, Van Ham TJ, Roberts LD, Gerszten RE, Macrae CA, Peterson RT
Journal of biomolecular screening - vol. 18 108-115 (2013)

Organophosphates are a class of highly toxic chemicals that includes many pesticides and chemical weapons. Exposure to organophosphates, either through accidents or acts of terrorism, poses a significant risk to human health and safety. Existing antidotes, in use for over 50 years, have modest efficacy and undesirable toxicities. Therefore, discovering new organophosphate antidotes is a […]

Publications
Zebrafish based small molecule screens for novel DMD drugs

Drug Discovery Today: Technologies

Kawahara G, Kunkel LM
Drug Discovery Today: Technologies - vol. 10 e91-e96 (2013)

Recently, a number of chemical and drug screens using zebrafish embryos have been published. Using zebrafish dystrophin mutants, we screened a chemical library for small molecules that modulate the muscle phenotype and identified seven small molecules that influence muscle pathology in dystrophin-null zebrafish. One chemical, aminophylline, which is known to be a non-selective phosphodiesterase (PDE) […]

Publications
Hit identification of novel heparanase inhibitors by structure- and ligand-based approaches

Bioorganic and Medicinal Chemistry

Gozalbes R, Mosulén S, Ortí L, Rodríguez-Díaz J, Carbajo RJ, Melnyk P, Pineda-Lucena A
Bioorganic and Medicinal Chemistry - vol. 21 1944-1951 (2013)

Heparanase is a key enzyme involved in the dissemination of metastatic cancer cells. In this study a combination of in silico techniques and experimental methods was used to identify new potential inhibitors against this target. A 3D model of heparanase was built from sequence homology and applied to the virtual screening of a library composed […]

Publications
The immunosuppressive drug azathioprine inhibits biosynthesis of the bacterial signal molecule cyclic-di-GMP by interfering with intracellular nucleotide pool availability

Applied Microbiology and Biotechnology

Antoniani D, Rossi E, Rinaldo S, Bocci P, Lolicato M, Paiardini A, Raffaelli N, Cutruzzol?? F, Landini P
Applied Microbiology and Biotechnology - vol. 97 7325-7336 (2013)

In Gram-negative bacteria, production of the signal molecule c-di-GMP by diguanylate cyclases (DGCs) is a key trigger for biofilm formation, which, in turn, is often required for the development of chronic bacterial infections. Thus, DGCs represent interesting targets for new chemotherapeutic drugs with anti-biofilm activity. We searched for inhibitors of the WspR protein, a Pseudomonas […]

Publications
Animal models in therapeutic drug discovery for oculopharyngeal muscular dystrophy

Drug Discovery Today: Technologies

Chartier A, Simonelig M
Drug Discovery Today: Technologies - vol. 10 e103-e108 (2013)

Oculopharyngeal muscular dystrophy (OPMD) is a late onset disease which affects specific muscles. No pharmacological treatments are currently available for OPMD. In recent years, genetically tractable models of OPMD-Drosophila and Caenorhabditis elegans-have been generated. Although these models have not yet been used for large-scale primary drug screening, they have been very useful in candidate approaches […]

Publications
A cell-free fluorometric high-throughput screen for inhibitors of Rtt109-catalyzed histone acetylation

PLoS ONE

Dahlin JL, Sinville R, Solberg J, Zhou H, Han J, Francis S, Strasser JM, John K, Hook DJ, Walters MA, Zhang Z
PLoS ONE - vol. 8 (2013)

The lysine acetyltransferase (KAT) Rtt109 forms a complex with Vps75 and catalyzes the acetylation of histone H3 lysine 56 (H3K56ac) in the Asf1-H3-H4 complex. Rtt109 and H3K56ac are vital for replication-coupled nucleosome assembly and genotoxic resistance in yeast and pathogenic fungal species such as Candida albicans. Remarkably, sequence homologs of Rtt109 are absent in humans. […]

Publications
A high-throughput screen of the GTPase activity of Escherichia coli EngA to find an inhibitor of bacterial ribosome biogenesis.

Journal of biomolecular screening

Bharat A, Blanchard JE, Brown ED
Journal of biomolecular screening - vol. 18 830-836 (2013)

The synthesis of ribosomes is an essential process, which is aided by a variety of trans-acting factors in bacteria. Among these is a group of GTPases essential for bacterial viability and emerging as promising targets for new antibacterial agents. Herein, we describe a robust high-throughput screening process for inhibitors of one such GTPase, the Escherichia […]

Publications
A general framework to characterize inhibitors of calmodulin: Use of calmodulin inhibitors to study the interaction between calmodulin and its calmodulin binding domains

Biochimica et Biophysica Acta - Molecular Cell Research

Audran E, Dagher R, Gioria S, Tsvetkov PO, Kulikova AA, Didier B, Villa P, Makarov AA, Kilhoffer MC, Haiech J
Biochimica et Biophysica Acta - Molecular Cell Research - vol. 1833 1720-1731 (2013)

The prominent role of Ca2+ in cell physiology is mediated by a whole set of proteins involved in Ca2+-signal generation, deciphering and arrest. Among these intracellular proteins, calmodulin (CaM) known as a prototypical calcium sensor, serves as a ubiquitous carrier of the intracellular calcium signal in all eukaryotic cell types. CaM is assumed to be […]

Publications
Development and validation of a high-throughput intrinsic ATPase activity assay for the discovery of MEKK2 inhibitors.

Journal of biomolecular screening

Ahmad S, Hughes MA, Johnson GL, Scott JE
Journal of biomolecular screening - vol. 18 388-399 (2013)

The kinase MEKK2 (MAP3K2) has recently been implicated in tumor growth and metastasis. Thus, selective inhibition of MEKK2 may be a novel strategy for cancer therapy. To identify inhibitors of MEKK2 kinase activity, we have developed a novel activity assay for MEKK2 based on the discovery that recombinant purified MEKK2 has intrinsic ATPase activity. This […]

Publications
Chemical library screening using a SPR-based inhibition in solution assay: Simulations and experimental validation

Analytical Chemistry

Choulier L, Nominé Y, Zeder-Lutz G, Charbonnier S, Didier B, Jung ML, Altschuh D
Analytical Chemistry - vol. 85 8787-8795 (2013)

We have developed a surface plasmon resonance (SPR)-based inhibition in solution assay (ISA) to search for inhibitors of the medium affinity (KD = 0.8 μM) interaction between an E6-derived peptide (E6peptide) immobilized on the sensor and a PDZ domain (MAGI-1 PDZ1) in the mobile phase. DZ domains are widespread protein-protein interaction modules that recognize the […]